{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:24:32Z","timestamp":1780986272501,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.neuropharm.2011.12.006","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T01:55:06Z","timestamp":1323914106000},"page":"2261-2266","source":"Crossref","is-referenced-by-count":13,"title":["Block of cloned Kv4.3 potassium channels by dapoxetine"],"prefix":"10.1016","volume":"62","author":[{"given":"Imju","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang June","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.12.006_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.106.106724","article-title":"Interaction of riluzole with the closed inactivated state of Kv4.3 channels","volume":"319","author":"Ahn","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0006-3495(01)75747-5","article-title":"Kv4 channels exhibit modulation of closed-state inactivation in inside-out patches","volume":"81","author":"Beck","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1152\/physrev.00039.2003","article-title":"Structure and function of Kv4-family transient potassium channels","volume":"84","author":"Birnbaum","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib4","first-page":"CD001396","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","article-title":"The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation","volume":"12","author":"Buckett","year":"1988","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.12.006_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/289537a0","article-title":"Dendritic release of dopamine in the substantia nigra","volume":"289","author":"Cheramy","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.12.006_bib7","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/00001756-200312190-00032","article-title":"Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4","volume":"14","author":"Choi","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.12.006_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0006-2952(01)00678-5","article-title":"Effects of (-)-epigallocatechin-3-gallate, the main component of green tea, on the cloned rat brain Kv1.5 potassium channels","volume":"62","author":"Choi","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0028-3908(01)00088-0","article-title":"Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1","volume":"41","author":"Choi","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.12.006_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2004.05.065","article-title":"Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons","volume":"1018","author":"Choi","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)35063-3","article-title":"Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3","volume":"291","author":"Choi","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.RES.79.4.659","article-title":"Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current","volume":"79","author":"Dixon","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/PL00006605","article-title":"K+ channel blocker modulation of the refractory period in spontaneously active guinea-pig ureters","volume":"27","author":"Exintaris","year":"1999","journal-title":"Urol. Res."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.eururo.2005.05.017","article-title":"Physiology of ejaculation: emphasis on serotonergic control","volume":"48","author":"Giuliano","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0896-6273(95)90152-3","article-title":"Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons","volume":"15","author":"Hausser","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.12.006_bib16","first-page":"37","article-title":"Emerging treatments for premature ejaculation: focus on dapoxetine","volume":"5","author":"Hellstrom","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1113\/jphysiol.1990.sp018173","article-title":"Characteristics of transient outward currents in single smooth muscle cells from the ureter of the guinea-pig","volume":"427","author":"Imaizumi","year":"1990","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib18","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1476-5381.2011.01210.x","article-title":"Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation","volume":"163","author":"Jeong","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.mcn.2004.06.011","article-title":"Molecular physiology and modulation of somatodendritic A-type potassium channels","volume":"27","author":"Jerng","year":"2004","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1176\/jnp.5.3.322","article-title":"Human brain fluoxetine concentrations","volume":"5","author":"Karson","year":"1993","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/tcrm.2007.3.2.277","article-title":"Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation","volume":"3","author":"Kendirci","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib23","first-page":"1988","article-title":"Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in\u00a0vivo study","volume":"163","author":"Kim","year":"2000","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/jpet.106.117747","article-title":"Open channel block of A-type, Kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine","volume":"321","author":"Kim","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11587660-000000000-00000","article-title":"Cardiovascular safety profile of dapoxetine during the premarketing evaluation","volume":"11","author":"Kowey","year":"2011","journal-title":"Drugs R D"},{"key":"10.1016\/j.neuropharm.2011.12.006_bib26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1248\/bpb.33.977","article-title":"Inhibitory action of fluvoxamine on Kv1.5 currents","volume":"33","author":"Lee","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/aps.2010.14","article-title":"Open channel block of Kv1.5 currents by citalopram","volume":"31","author":"Lee","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0091270009333486","article-title":"Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects","volume":"49","author":"Modi","year":"2009","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib29","doi-asserted-by":"crossref","first-page":"C860","DOI":"10.1152\/ajpcell.1997.272.3.C860","article-title":"Effects of arachidonic acid on A-type potassium currents in smooth muscle cells of the guinea pig","volume":"272","author":"Nagano","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)39034-2","article-title":"Neuroreceptors and ion channels as the basis for drug action: past, present, and future","volume":"294","author":"Narahashi","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(97)01483-X","article-title":"Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel \u03b1-subunit, Kv4.3 in the rat","volume":"420","author":"Ohya","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-3565(24)29480-5","article-title":"Effects of anorexinogen agents on cloned voltage-gated K+ channel hKv1.5","volume":"298","author":"Perchenet","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.1995.tb16636.x","article-title":"Ionic currents and inhibitory effects of glibenclamide in seminal vesicle smooth muscle cells","volume":"115","author":"Sadraei","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0022-3565(24)36805-3","article-title":"The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices","volume":"282","author":"Schechter","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.RES.77.3.575","article-title":"Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel","volume":"77","author":"Snyders","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.300.2.543","article-title":"The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels","volume":"300","author":"Thomas","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.bjp.0701545","article-title":"Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1)","volume":"122","author":"Tytgat","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib39","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1529\/biophysj.105.059378","article-title":"Time- and voltage-dependent components of Kv4.3 inactivation","volume":"89","author":"Wang","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0024-3205(95)00209-O","article-title":"Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication","volume":"57","author":"Wong","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1085\/jgp.61.6.687","article-title":"Ionic blockage of sodium channels in nerve","volume":"61","author":"Woodhull","year":"1973","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2011.12.006_bib42","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/sj.bjp.0702955","article-title":"Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine","volume":"128","author":"Yeung","year":"1999","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811005107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811005107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T21:25:31Z","timestamp":1742073931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811005107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0028390811005107"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}